Suppr超能文献

二磷酸腺苷对肌球蛋白V三磷酸腺苷酶活性的抑制作用。

ADP inhibition of myosin V ATPase activity.

作者信息

De La Cruz E M, Sweeney H L, Ostap E M

机构信息

University of Pennsylvania School of Medicine, Department of Physiology, and the Pennsylvania Muscle Institute, Philadelphia, Pennsylvania 19104-6085 USA.

出版信息

Biophys J. 2000 Sep;79(3):1524-9. doi: 10.1016/S0006-3495(00)76403-4.

Abstract

The kinetic mechanism of myosin V is of great interest because recent evidence indicates that the two-headed myosin V molecule functions as a processive motor, i.e., myosin V is capable of moving along an actin filament for many catalytic cycles of the motor without dissociating. Three recent publications assessing the kinetics of single-headed myosin V provide different conclusions regarding the mechanism, particularly the rate-limiting step of the cycle. One study (, Proc. Natl. Acad. Sci. USA. 96:13726-13731) identifies ADP release as the rate-limiting step and provides a kinetic explanation for myosin V processivity. The others (, J. Biol. Chem. 274:27448-27456;, J. Biol. Chem. 275:4329-4335) do not identify the rate-limiting step but conclude that it is not ADP release. We show experimental and simulated data demonstrating that the inconsistencies in the reports may be due to difficulties in the measurement of the steady-state ATPase rate. Under standard assay conditions, ADP competes with ATP, resulting in product inhibition of the ATPase rate. This presents technical problems in analyzing and interpreting the kinetics of myosin V and likely of other members of the myosin family with high ADP affinities.

摘要

肌球蛋白V的动力学机制备受关注,因为最近的证据表明,双头肌球蛋白V分子起着持续性运动蛋白的作用,即肌球蛋白V能够沿着肌动蛋白丝进行多个催化循环的运动而不解离。最近有三篇评估单头肌球蛋白V动力学的论文,关于其机制,特别是循环的限速步骤,得出了不同的结论。一项研究(《美国国家科学院院刊》96:13726 - 13731)将ADP释放确定为限速步骤,并为肌球蛋白V的持续性提供了动力学解释。其他两项研究(《生物化学杂志》274:27448 - 27456;《生物化学杂志》275:4329 - 4335)没有确定限速步骤,但得出结论认为不是ADP释放。我们展示的实验和模拟数据表明,报告中的不一致可能是由于稳态ATP酶速率测量存在困难。在标准测定条件下,ADP与ATP竞争,导致对ATP酶速率的产物抑制。这在分析和解释肌球蛋白V以及可能其他具有高ADP亲和力的肌球蛋白家族成员的动力学方面带来了技术问题。

相似文献

1
ADP inhibition of myosin V ATPase activity.
Biophys J. 2000 Sep;79(3):1524-9. doi: 10.1016/S0006-3495(00)76403-4.
2
Kinetic mechanism of Nicotiana tabacum myosin-11 defines a new type of a processive motor.
FASEB J. 2015 Jan;29(1):81-94. doi: 10.1096/fj.14-254763. Epub 2014 Oct 17.
3
Actin and light chain isoform dependence of myosin V kinetics.
Biochemistry. 2000 Nov 21;39(46):14196-202. doi: 10.1021/bi001701b.
4
The kinetic mechanism of myosin V.
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13726-31. doi: 10.1073/pnas.96.24.13726.
6
Mechanoenzymatic characterization of human myosin Vb.
Biochemistry. 2006 Feb 28;45(8):2729-38. doi: 10.1021/bi051682b.
8
Biochemical kinetic characterization of the Acanthamoeba myosin-I ATPase.
J Cell Biol. 1996 Mar;132(6):1053-60. doi: 10.1083/jcb.132.6.1053.
9
Kinetic characterization of the ATPase and actin-activated ATPase activities of Acanthamoeba castellanii myosin-2.
J Biol Chem. 2013 Sep 13;288(37):26709-20. doi: 10.1074/jbc.M113.485946. Epub 2013 Jul 29.
10
Human myosin Vc is a low duty ratio, nonprocessive molecular motor.
J Biol Chem. 2008 Mar 28;283(13):8527-37. doi: 10.1074/jbc.M709150200. Epub 2008 Jan 16.

引用本文的文献

1
Switch-2 determines MgADP-release kinetics and fine-tunes the duty ratio of class-1 myosins.
Front Physiol. 2024 Jun 3;15:1393952. doi: 10.3389/fphys.2024.1393952. eCollection 2024.
3
Deafness mutation in the MYO3A motor domain impairs actin protrusion elongation mechanism.
Mol Biol Cell. 2022 Jan 1;33(1):ar5. doi: 10.1091/mbc.E21-05-0232. Epub 2021 Nov 17.
4
Cardiomyopathy mutations impact the actin-activated power stroke of human cardiac myosin.
Biophys J. 2021 Jun 1;120(11):2222-2236. doi: 10.1016/j.bpj.2021.04.007. Epub 2021 Apr 20.
5
Optical control of fast and processive engineered myosins in vitro and in living cells.
Nat Chem Biol. 2021 May;17(5):540-548. doi: 10.1038/s41589-021-00740-7. Epub 2021 Feb 18.
6
Switch-1 instability at the active site decouples ATP hydrolysis from force generation in myosin II.
Cytoskeleton (Hoboken). 2021 Jan;78(1):3-13. doi: 10.1002/cm.21650. Epub 2021 Jan 11.
7
Dilated cardiomyopathy mutation in the converter domain of human cardiac myosin alters motor activity and response to omecamtiv mecarbil.
J Biol Chem. 2019 Nov 15;294(46):17314-17325. doi: 10.1074/jbc.RA119.010217. Epub 2019 Oct 2.
8
Bacillus subtilis DisA regulates RecA-mediated DNA strand exchange.
Nucleic Acids Res. 2019 Jun 4;47(10):5141-5154. doi: 10.1093/nar/gkz219.
9
MutS Modulates RecA-Mediated DNA Strand Exchange Between Divergent DNA Sequences.
Front Microbiol. 2019 Feb 13;10:237. doi: 10.3389/fmicb.2019.00237. eCollection 2019.
10
Toxin ζ Reduces the ATP and Modulates the Uridine Diphosphate-N-acetylglucosamine Pool.
Toxins (Basel). 2019 Jan 9;11(1):29. doi: 10.3390/toxins11010029.

本文引用的文献

1
Effect of ADP and ionic strength on the kinetic and motile properties of recombinant mouse myosin V.
J Biol Chem. 2000 Feb 11;275(6):4329-35. doi: 10.1074/jbc.275.6.4329.
2
The kinetic mechanism of myosin V.
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13726-31. doi: 10.1073/pnas.96.24.13726.
3
Kinetic characterization of a monomeric unconventional myosin V construct.
J Biol Chem. 1999 Sep 24;274(39):27448-56. doi: 10.1074/jbc.274.39.27448.
4
Myosin-V is a processive actin-based motor.
Nature. 1999 Aug 5;400(6744):590-3. doi: 10.1038/23072.
7
Kinetic characterization of brush border myosin-I ATPase.
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14332-7. doi: 10.1073/pnas.94.26.14332.
8
Motor proteins: myosin V--the multi-purpose transport motor.
Curr Biol. 1997 May 1;7(5):R301-4. doi: 10.1016/s0960-9822(06)00143-6.
9
Unconventional myosins.
Annu Rev Cell Dev Biol. 1995;11:633-75. doi: 10.1146/annurev.cb.11.110195.003221.
10
Special instrumentation and techniques for kinetic studies of contractile systems.
Methods Enzymol. 1982;85 Pt B:698-708. doi: 10.1016/0076-6879(82)85057-x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验